Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-6,500
Closed -$342K 601
2017
Q4
$342K Sell
6,500
-9,592
-60% -$505K 0.31% 31
2017
Q3
$900K Buy
+16,092
New +$851K 1.18% 27
2015
Q3
Sell
-268
Closed -$10.6K 424
2015
Q2
$10.6K Buy
+268
New +$8.35K 0.01% 317

Other funds holding AMED

FNY Managed Accounts's AMED Position: Q1 2018 in Review

FNY Managed Accounts sold out of Amedisys (AMED) in Q1 2018, closing a stake of 6,500 shares — an estimated $342K sold.

FNY Managed Accounts first reported a position in AMED in Q2 2015 and held it in 3 quarters. The position peaked at $900K in Q3 2017. 194 funds tracked by Wall St. Rank hold AMED as of Q1 2018.

  • FNY Managed Accounts reported no remaining Amedisys position as of Q1 2018 after selling out during the quarter.
  • FNY Managed Accounts sold 6,500 Amedisys shares in Q1 2018, an estimated $342K.
  • FNY Managed Accounts first reported a position in Amedisys in Q2 2015 and held it in 3 quarters.
  • FNY Managed Accounts's Amedisys position peaked at $900K in Q3 2017.
  • 194 funds tracked by Wall St. Rank held Amedisys as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.